Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ki-Hye Kim

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Cells|July 2, 2021
Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic SyndromeChong-Hyun Shin, Ki-Hye Kim, Subbiah Jeeva, et al.
Vaccines|September 28, 2021
An Update on mRNA-Based Viral VaccinesSubbiah Jeeva, Ki-Hye Kim, Chong Hyun Shin, et al.
Immune Network|November 3, 2017
Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza VaccinationEun-Ju Ko, Young-Tae Lee, Youri Lee, et al.
Expert Review of Vaccines|April 9, 2016
Progress in developing virus-like particle influenza vaccinesFu-Shi Quan, Young-Tae Lee, Ki-Hye Kim, et al.
Scientific Reports|December 8, 2022
Effective adjuvantation of nanograms of influenza vaccine and induction of cross-protective immunity by physical radiofrequency adjuvantZhuofan Li, Xinliang Kang, Ki-Hye Kim, et al.
Human Vaccines & Immunotherapeutics|April 20, 2021
Natural killer cells contribute to enhanced respiratory disease after oil-in-water emulsion adjuvanted vaccination against respiratory syncytial virus and infectionYoonsuh Park, Ki-Hye Kim, Youri Lee, et al.
Antiviral Research|June 10, 2018
MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccineEun-Ju Ko, Youri Lee, Young-Tae Lee, et al.
Vaccine|October 13, 2010
Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugationTae-Hyun Paik, Ji-Sook Lee, Ki-Hye Kim, et al.
Antiviral Research|December 21, 2021
Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged miceNoopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, et al.
Vaccines|December 4, 2020
Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial VirusYu-Jin Jung, Yu-Na Lee, Ki-Hye Kim, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Cells|July 2, 2021
Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic SyndromeChong-Hyun Shin, Ki-Hye Kim, Subbiah Jeeva, et al.
Vaccines|September 28, 2021
An Update on mRNA-Based Viral VaccinesSubbiah Jeeva, Ki-Hye Kim, Chong Hyun Shin, et al.
Immune Network|November 3, 2017
Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza VaccinationEun-Ju Ko, Young-Tae Lee, Youri Lee, et al.
Expert Review of Vaccines|April 9, 2016
Progress in developing virus-like particle influenza vaccinesFu-Shi Quan, Young-Tae Lee, Ki-Hye Kim, et al.
Scientific Reports|December 8, 2022
Effective adjuvantation of nanograms of influenza vaccine and induction of cross-protective immunity by physical radiofrequency adjuvantZhuofan Li, Xinliang Kang, Ki-Hye Kim, et al.
Human Vaccines & Immunotherapeutics|April 20, 2021
Natural killer cells contribute to enhanced respiratory disease after oil-in-water emulsion adjuvanted vaccination against respiratory syncytial virus and infectionYoonsuh Park, Ki-Hye Kim, Youri Lee, et al.
Antiviral Research|June 10, 2018
MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccineEun-Ju Ko, Youri Lee, Young-Tae Lee, et al.
Vaccine|October 13, 2010
Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugationTae-Hyun Paik, Ji-Sook Lee, Ki-Hye Kim, et al.
Antiviral Research|December 21, 2021
Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged miceNoopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, et al.
Vaccines|December 4, 2020
Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial VirusYu-Jin Jung, Yu-Na Lee, Ki-Hye Kim, et al.
Pageof 10